David E. Krysztof

2.6k total citations · 1 hit paper
35 papers, 1.8k citations indexed

About

David E. Krysztof is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, David E. Krysztof has authored 35 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 16 papers in Public Health, Environmental and Occupational Health and 15 papers in Epidemiology. Recurrent topics in David E. Krysztof's work include Mosquito-borne diseases and control (14 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (11 papers). David E. Krysztof is often cited by papers focused on Mosquito-borne diseases and control (14 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (11 papers). David E. Krysztof collaborates with scholars based in United States, Canada and Austria. David E. Krysztof's co-authors include Susan L. Stramer, Gregory A. Foster, Roger Y. Dodd, Edward P. Notari, Jean K. Lim, Shimian Zou, Fatemeh Musavi, James Duehr, Florian Krammer and Julia A. Brown and has published in prestigious journals such as Science, New England Journal of Medicine and Immunity.

In The Last Decade

David E. Krysztof

34 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

2017 387 citations Susana V. Bardina, Shashank Tripathi et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Krysztof United States	20	906	846	709	395	274	35	1.8k
Gregory A. Foster United States	22	1.4k 1.6×	1.4k 1.7×	805 1.1×	480 1.2×	237 0.9×	46	2.6k
Sally Caglioti United States	16	710 0.8×	580 0.7×	826 1.2×	552 1.4×	283 1.0×	18	1.6k
Clive R. Seed Australia	25	627 0.7×	472 0.6×	1.1k 1.6×	950 2.4×	516 1.9×	96	2.0k
Nanci A. Salles Brazil	16	242 0.3×	234 0.3×	389 0.5×	148 0.4×	231 0.8×	42	718
Ruth Offergeld Germany	16	199 0.2×	128 0.2×	306 0.4×	198 0.5×	246 0.9×	54	749
J. Saldanha United Kingdom	22	755 0.8×	316 0.4×	1.1k 1.5×	912 2.3×	43 0.2×	67	1.9k
Jean Pierre Allain United Kingdom	17	474 0.5×	75 0.1×	483 0.7×	236 0.6×	159 0.6×	30	1.3k
Marion Vermeulen United States	18	911 1.0×	66 0.1×	747 1.1×	579 1.5×	330 1.2×	56	1.7k
David O. Irving Australia	22	144 0.2×	937 1.1×	317 0.4×	37 0.1×	167 0.6×	82	2.0k
Peter L. Page United States	9	371 0.4×	354 0.4×	177 0.2×	43 0.1×	111 0.4×	13	748

Countries citing papers authored by David E. Krysztof

Since Specialization

Citations

This map shows the geographic impact of David E. Krysztof's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Krysztof with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Krysztof more than expected).

Fields of papers citing papers by David E. Krysztof

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Krysztof. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Krysztof. The network helps show where David E. Krysztof may publish in the future.

Co-authorship network of co-authors of David E. Krysztof

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Krysztof. A scholar is included among the top collaborators of David E. Krysztof based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Krysztof. David E. Krysztof is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stone, Mars, Bryan R. Spencer, Rebecca V. Fink, et al.. (2024). Patient and Immunological Factors Associated With Delayed Clearance of Mucosal Severe Acute Respiratory Syndrome Coronavirus 2 RNA and Symptom Persistence. The Journal of Infectious Diseases. 230(2). 357–362.

Stramer, Susan L., Marion C. Lanteri, Jaye P. Brodsky, et al.. (2022). Mitigating the risk of transfusion‐transmitted infections with vector‐borne agents solely by means of pathogen reduction. Transfusion. 62(7). 1388–1398. 9 indexed citations

Acklin, Joshua A., Julia A. Brown, Gregory A. Foster, et al.. (2021). Evaluating the Safety of West Nile Virus Immunity During Congenital Zika Virus Infection in Mice. Frontiers in Immunology. 12. 686411–686411. 5 indexed citations

Duehr, James, Gursewak Singh, Gregory A. Foster, et al.. (2018). Tick-Borne Encephalitis Virus Vaccine-Induced Human Antibodies Mediate Negligible Enhancement of Zika Virus Infection In Vitro and in a Mouse Model. mSphere. 3(1). 17 indexed citations

Bardina, Susana V., Shashank Tripathi, James Duehr, et al.. (2017). Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science. 356(6334). 175–180. 387 indexed citations breakdown →

Vahidnia, Farnaz, Susan L. Stramer, Debra Kessler, et al.. (2016). Recent viral infection in US blood donors and health-related quality of life (HRQOL). Quality of Life Research. 26(2). 349–357. 18 indexed citations

Hoffman, Kevin W., David Sachs, Susana V. Bardina, et al.. (2016). Differences in Early Cytokine Production Are Associated With Development of a Greater Number of Symptoms Following West Nile Virus Infection. The Journal of Infectious Diseases. 214(4). 634–643. 14 indexed citations

Vahidnia, Farnaz, Susan L. Stramer, Debra Kessler, et al.. (2016). Motivations for donating and attitudes toward screening policies in US blood donors with viral infection. Transfusion. 56(8). 2013–2020. 20 indexed citations

Custer, Brian, Debra Kessler, Farnaz Vahidnia, et al.. (2014). Risk factors for retrovirus and hepatitis virus infections in accepted blood donors. Transfusion. 55(5). 1098–1107. 42 indexed citations

10.

Stramer, Susan L., Edward P. Notari, David E. Krysztof, & Roger Y. Dodd. (2013). Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?. Transfusion. 53(10pt2). 2449–2458. 69 indexed citations

11.

Stramer, Susan L., et al.. (2013). Comparative analysis of triplex nucleic acid test assays in United States blood donors. Transfusion. 53(10pt2). 2525–2537. 48 indexed citations

12.

Stramer, Susan L., Jeffrey M. Linnen, Gregory A. Foster, et al.. (2012). Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion. 52(8). 1657–1666. 150 indexed citations

13.

Delwart, Eric, Beth Slikas, Susan L. Stramer, et al.. (2012). Genetic Diversity of Recently Acquired and Prevalent HIV, Hepatitis B Virus, and Hepatitis C Virus Infections in US Blood Donors. The Journal of Infectious Diseases. 205(6). 875–885. 45 indexed citations

14.

Stramer, Susan L., et al.. (2011). Sensitivity comparison of two Food and Drug Administration–licensed, triplex nucleic acid test automated assays for hepatitis B virus DNA detection and associated projections of United States yield. Transfusion. 51(9). 2012–2022. 19 indexed citations

15.

Stramer, Susan L., Shimian Zou, Edward P. Notari, et al.. (2011). Blood donation screening for hepatitis B virus markers in the era of nucleic acid testing: are all tests of value?. Transfusion. 52(2). 440–446. 52 indexed citations

16.

Stramer, Susan L., Edward P. Notari, Shimian Zou, et al.. (2010). Human T‐lymphotropic virus antibody screening of blood donors: rates of false‐positive results and evaluation of a potential donor reentry algorithm. Transfusion. 51(4). 692–701. 20 indexed citations

17.

Zou, Shimian, Kerri Dorsey, Edward P. Notari, et al.. (2010). Prevalence, incidence, and residual risk of human immunodeficiency virus and hepatitis C virus infections among United States blood donors since the introduction of nucleic acid testing. Transfusion. 50(7). 1495–1504. 189 indexed citations

18.

Lim, Jean K., Andrea Lisco, David H. McDermott, et al.. (2009). Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man. PLoS Pathogens. 5(2). e1000321–e1000321. 164 indexed citations

19.

Zou, Shimian, Susan L. Stramer, Edward P. Notari, et al.. (2009). Current incidence and residual risk of hepatitis B infection among blood donors in the United States. Transfusion. 49(8). 1609–1620. 78 indexed citations

20.

Lim, Jean K., David H. McDermott, Andrea Lisco, et al.. (2009). CCR5 Deficiency Is a Risk Factor for Early Clinical Manifestations of West Nile Virus Infection but not for Viral Transmission. The Journal of Infectious Diseases. 201(2). 178–185. 102 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact